SCHEMBL7224974

SCHEMBL7224974

Cc1ccccc1[CH]C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
ALDH1A1 P00352 3/20 0.50
ACHE P22303 3/20 0.48
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
RAB9A P51151 4/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PABPC1 P11940 1/20 0.36
TTR P02766 1/20 0.34
TP53 P04637 1/20 0.34
CYP2D6 P10635 1/20 0.34
THPO P40225 1/20 0.34
HIF1A Q16665 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1229938 0.77 ALDH1A1 (0.46) TSHRALDH1A1ACHEMAPTKDM4E
SCHEMBL1229940 0.77 ALDH1A1 (0.46) TSHRALDH1A1ACHEMAPTKDM4E
SCHEMBL3219076 0.76 TSHR (0.50) TSHRALDH1A1ACHEMAPTKDM4E
Acrylonitrile SCHEMBL8511291 0.76 ALDH1A1 (0.45) TSHRALDH1A1ACHEMAPTKDM4E
O-Xylene SCHEMBL10631602 0.75 TSHR (0.53) TSHRALDH1A1ACHEMAPTKDM4E
O-Xylene SCHEMBL1443689 0.73 TSHR (0.67) TSHRALDH1A1ACHEMAPTRAB9A
O-Xylene SCHEMBL27496500 0.73 TSHR (0.67) TSHRALDH1A1ACHEMAPTKDM4E
Acrylonitrile SCHEMBL19691715 0.73 TSHR (0.42) TSHRALDH1A1ACHEMAPTKDM4E
SCHEMBL31571540 0.73 ALDH1A1 (0.42) TSHRALDH1A1ACHEMAPTKDM4E
SCHEMBL10396571 0.73 ALDH1A1 (0.42) TSHRALDH1A1ACHEMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6531612-B2 Pyrrolidine-2-carboxylic acid cyano-methyl amide derivatives useful for treating diseases associated with cystein proteases, such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis HOFFMAN-LA ROCHE INC. 2003-03-11 US disclosed